SCHEMBL7969987

SCHEMBL7969987

c1ccc(CN2CCC(Nc3nc4ccccc4n4cncc34)C2)cc1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LCK P06239 12/20 0.66
OPRK1 P41145 1/20 0.53
ROCK2 O75116 2/20 0.50
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.47
NTSR1 P30989 1/20 0.47
HTT P42858 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
GBA1 P04062 1/20 0.47
POLB P06746 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
SSTR5 P35346 1/20 0.47
CCR2 P41597 1/20 0.47
ROCK1 Q13464 1/20 0.47
BCHE P06276 1/20 0.46
ACHE P22303 1/20 0.46
BACE1 P56817 1/20 0.46
CYP3A4 P08684 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969983 1.00 LCK (0.66) LCKOPRK1ROCK2LMNAMAPT
SCHEMBL7983738 0.81 LCK (1.00) LCKSMN1; SMN2
SCHEMBL7979842 0.78 LCK (0.74) LCKSMN1; SMN2
SCHEMBL7979976 0.77 LCK (1.00) LCKKMT2ASMN1; SMN2
SCHEMBL6696801 0.75 ROCK2 (0.48) OPRK1ROCK2CCR2ROCK1BCHE
SCHEMBL4041014 0.73 LCK (0.56) LCK
SCHEMBL7980641 0.72 LCK (0.67) LCK
SCHEMBL7970011 0.72 HTR3E (0.72) LMNAMAPT
SCHEMBL331018 0.70 BCHE (0.68) OPRK1ROCK2KMT2ACCR2ROCK1
SCHEMBL331017 0.70 BCHE (0.68) OPRK1ROCK2KMT2ACCR2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed